Tao Zhang

发表

Sparing Organs at Risk with Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Locally Advanced Non-Small Cell Lung Cancer: An Automatic Treatment Planning Study

Xiaodong Zhang, J. Dai, Zongmei Zhou, 2020, Cancer management and research.

Prediction of Radiation Pneumonitis With Dose Distribution: A Convolutional Neural Network (CNN) Based Model

J. Dai, Hui Yan, Zongmei Zhou, 2020, Frontiers in Oncology.

A deep learning-based dual-omics prediction model for radiation pneumonitis.

P. Huang, J. Dai, Z. Su, 2021, Medical physics.

Anlotinib combined with durvalumab in a patient with recurrent multifocal brain metastases of small cell lung cancer after definitive concurrent chemoradiotherapy and palliative radiotherapy of the lung and brain: a case report.

Jianyang Wang, N. Bi, Tao Zhang, 2021, Annals of palliative medicine.

A Special Report on 2019 International Planning Competition and a Comprehensive Analysis of Its Results

J. Dai, S. Bai, Xuetao Wang, 2020, Frontiers in Oncology.

Evaluation of Automatic Segmentation Model With Dosimetric Metrics for Radiotherapy of Esophageal Cancer

J. Dai, K. Men, Ji Zhu, 2020, Frontiers in Oncology.

Factors affecting the completion of concurrent chemotherapy and impact of non-completion on survival in locally advanced esophageal squamous cell carcinoma

Jun Liang, Zongmei Zhou, Zefen Xiao, 2022, Esophagus.

Treatment outcomes of patients with stage III non–small cell lung cancer and interstitial lung diseases receiving intensity‐modulated radiation therapy: A single‐center experience of 85 cases

Jun Liang, Zongmei Zhou, Zefen Xiao, 2022, Thoracic cancer.

Clinical outcomes and radiation pneumonitis after concurrent EGFR‐tyrosine kinase inhibitors and radiotherapy for unresectable stage III non‐small cell lung cancer

Jun Liang, Jianyang Wang, Jie Wang, 2021, Thoracic cancer.

Tracheoesophageal fistula associated with bevacizumab after thoracic radiotherapy in non-small cell lung cancer

Y. Yang, N. Bi, Tao Zhang, 2020, Medicine.

The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non-small cell lung cancer receiving chemoradiotherapy

Xin Wang, Jun Liang, Jianyang Wang, 2020, Journal of thoracic disease.

Comparison between atlas and convolutional neural network based automatic segmentation of multiple organs at risk in non-small cell lung cancer

K. Men, Xin Wang, N. Bi, 2020, Medicine.

Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non–Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants

Jun Liang, Chen Hu, Xu Yang, 2019, JAMA network open.

Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial

Jun Liang, Xu Yang, Zongmei Zhou, 2020, Radiation Oncology.

Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy

Jun Liang, Jianyang Wang, Zongmei Zhou, 2022, Therapeutic advances in medical oncology.

A Single Center Analysis of Thymic Neuroendocrine Tumors

Junling Li, Jianyang Wang, Zongmei Zhou, 2022, Cancers.

A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk Analysis

Jun Liang, Jianyang Wang, Xu Yang, 2021, Frontiers in Oncology.

Durvalumab after concurrent chemoradiotherapy in a patient with chemotherapy-resistant unresectable stage III non-small cell lung cancer: a case report.

Shan Zheng, N. Bi, Tao Zhang, 2020, Annals of palliative medicine.

A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol

Jun Liang, Jianyang Wang, Zongmei Zhou, 2020, BMC cancer.

Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma

Jun Liang, Zongmei Zhou, Q. Feng, 2020, BMC Cancer.

Factors affecting the completion of concurrent chemotherapy and impact of non-completion on survival in locally advanced esophageal squamous cell carcinoma

Jun Liang, Zongmei Zhou, Q. Feng, 2022, Esophagus.

Development of a competing risk nomogram for the prediction of cause-specific mortality in patients with thymoma: a population-based analysis

B. Qiu, Tao Zhang, Lipin Liu, 2021, Journal of thoracic disease.

Organ at risks sparing with simultaneous integrated boost volumetric modulated arc therapy for locally advanced non-small lung cancer: an automated treatment planning study

Xiaodong Zhang, J. Dai, Zongmei Zhou, 2020 .

Transcriptome alteration spectrum in rat lung induced by radiotherapy

N. Bi, Li Sun, L. Deng, 2019, Scientific Reports.

Silence of S1 RNA binding domain 1 represses cell growth and promotes apoptosis in human non-small cell lung cancer cells.

Y. Yang, B. Qiu, D. Su, 2019, Translational lung cancer research.

A Validation Study on the Lung Immune Prognostic Index for Prognostic Value in Patients with Locally Advanced Non-Small Cell Lung Cancer.

Jun Liang, Jianyang Wang, Zongmei Zhou, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Complete response induced by anti–PD‐1‐based immunotherapy with toripalimab in a patient with locally advanced lung adenocarcinoma who failed rapidly after concurrent chemoradiotherapy: A case report

J. Duan, Xin Wang, N. Bi, 2020, Journal of clinical pharmacy and therapeutics.

A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer

Tao Zhang, Jun Liang, Zongmei Zhou, 2019, Radiation Oncology.

Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis

Jun Liang, Zongmei Zhou, Q. Feng, 2021, Frontiers in Oncology.

Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score‐matched analysis

Jun Liang, Zongmei Zhou, Q. Feng, 2021, Thoracic Cancer.

Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial

Jun Liang, Xu Yang, Zongmei Zhou, 2021, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

S-1–Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial

W. Wang, Jun Liang, Xinchen Sun, 2020, Frontiers in Oncology.

Efficacy and safety of immune checkpoint inhibitor consolidation after chemoradiation in patients of Asian ethnicity with unresectable stage III non‐small cell lung cancer: Chinese multicenter report and literature review

Wei Jiang, Jun Liang, Jianyang Wang, 2020, Thoracic cancer.

Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study

Jun Liang, Zongmei Zhou, Q. Feng, 2019, Radiation Oncology.

The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases

Jun Liang, Junling Li, Zongmei Zhou, 2019, Journal of Cancer.

Local Therapy Combined With First-Line EGFR Tyrosine Kinase Inhibitor Achieves Favorable Survival in Patients With EGFR-Mutant Metastatic Non-Small Cell Lung Cancer

Jun Liang, Jianyang Wang, Zongmei Zhou, 2022, Clinical Medicine Insights. Oncology.

Radiation pneumonitis complicated by Pneumocystis carinii in patients with thoracic neoplasia: a clinical analysis of 7 cases

Jun Liang, Xu Yang, Zongmei Zhou, 2019, Cancer communications.

CNN-Based Quality Assurance for Automatic Segmentation of Breast Cancer in Radiotherapy

Bo Chen, Tao Zhang, Xinyuan Chen, 2020, Frontiers in Oncology.

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma

Q. Xue, Jun Liang, Y. Mao, 2022, Frontiers in Oncology.

Deep Learning Improved Clinical Target Volume Contouring Quality and Efficiency for Postoperative Radiation Therapy in Non-small Cell Lung Cancer

Jianrong Dai, Xinyuan Chen, Junjie Miao, 2019, Front. Oncol..

Development and validation of a prediction model using molecular marker for long‐term survival in unresectable stage III non‐small cell lung cancer treated with chemoradiotherapy

Jun Liang, Jianyang Wang, Zongmei Zhou, 2021, Thoracic cancer.

Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma

Jun Liang, Zongmei Zhou, Q. Feng, 2020, BMC Cancer.

Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.

K. Shao, Q. Xue, Jie He, 2020, The oncologist.

Induction Immune Checkpoint Inhibitors and Chemotherapy before Definitive Chemoradiation Therapy for Patients with Bulky Unresectable Stage III Non-small-cell Lung Cancer.

Q. Xue, Jianyang Wang, Zhijie Wang, 2023, International journal of radiation oncology, biology, physics.

Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis123

Wei Jiang, Jun Liang, Zongmei Zhou, 2018, Translational oncology.

Novel long noncoding RNA (lncRNA) panel as biomarkers for prognosis in lung squamous cell carcinoma via competitive endogenous RNA (ceRNA) network analysis

B. Qiu, D. Su, L. Deng, 2021, Translational cancer research.

Inter‐ and intrafractional setup errors and baseline shifts of fiducial markers in patients with liver tumors receiving free‐breathing postoperative radiation analyzed by cone‐beam computed tomography

Shulian Wang, J. Jin, Weihu Wang, 2014, Journal of applied clinical medical physics.

The effect of image-guided radiation therapy on the margin between the clinical target volume and planning target volume in lung cancer

J. Dai, Jun Liang, Yin Zhang, 2014, Journal of medical radiation sciences.

Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma

Shulian Wang, J. Jin, H. Fang, 2016, Medicine.

Prognostic value of circulating tumour DNA during post‐radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma

Yang Xu, Jianyang Wang, Yin Li, 2022, Clinical and translational medicine.

Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy

Shulian Wang, J. Jin, Weihu Wang, 2010, Radiation oncology.

Study of match methods in cone beam computed tomography online correction for postoperative radiotherapy in liver cancer patients

Shulian Wang, J. Jin, Weihu Wang, 2013 .

Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma

Xinchen Sun, Jianyang Wang, Zongmei Zhou, 2023, JAMA network open.

Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey

Jun Liang, Xinchen Sun, Zongmei Zhou, 2021, Acta oncologica.

Postoperative radiotherapy for pathological stage IIIA‐N2 non‐small cell lung cancer with positive surgical margins

Jun Liang, Jianyang Wang, Xu Yang, 2020, Thoracic cancer.

Jun Liang, Zongmei Zhou, Q. Feng, 2019, Radiation oncology.

Increased CYFRA 21-1 , CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung : A Nomogram and Recursive Partitioning Risk Stratification Analysis 1 , 2 , 3

Wei Jiang, Zongmei Zhou, Q. Feng, 2018 .

Real-world Safety and Efficacy of Consolidation Durvalumab after Chemoradiotherapy for Stage III Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis.

Y. Yang, Luhua Wang, N. Bi, 2021, International journal of radiation oncology, biology, physics.

Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial

Wei Chen, Z. Zhou, Y. Shyr, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer

Q. Xue, Jianyang Wang, Zongmei Zhou, 2023, Frontiers in immunology.

Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study)

Jianyang Wang, Zongmei Zhou, Q. Feng, 2024, Frontiers in Immunology.

Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy

Tao Zhang, Wenqing Wang, Yuqi Wu, 2024, Journal of the National Cancer Center.

Longitudinal circulating tumour DNA dynamics predict failure patterns and efficacy of consolidation immunotherapy after chemoradiotherapy in locally advanced non‐small‐cell lung cancer

Jianyang Wang, Tao Zhang, Yuqi Wu, 2024, Clinical and translational medicine.

Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II study

Zongmei Zhou, Q. Feng, Y. Zhai, 2024, BMC Cancer.

Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study.

Zongmei Zhou, Q. Feng, Tao Zhang, 2024, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].